
1. j virol. 2010 mar;84(6):2946-54. doi: 10.1128/jvi.01779-09. epub 2009 dec 30.

activation peroxisome proliferator-activated receptor gamma human
cytomegalovirus de novo replication impairs migration invasiveness of
cytotrophoblasts early placentas.

rauwel b(1), mariam√© b, martin h, nielsen r, allart s, pipy b, mandrup s,
devignes md, evain-brion d, fournier t, davrinche c.

author information: 
(1)nserm, u563, toulouse f-31300, france.

human cytomegalovirus (hcmv) contributes pathogenic processes in
immunosuppressed individuals, fetuses, neonates. present report,
by using reporter gene activation assays confocal microscopy presence 
of specific antagonist, show first time hcmv infection induces 
peroxisome proliferator-activated receptor gamma (ppargamma) transcriptional
activity infected cells. demonstrate ppargamma antagonist
dramatically impairs virus production major immediate-early promoter
contains ppar response elements able bind ppargamma, assessed by
electrophoretic mobility shift chromatin immunoprecipitation assays. due to
the key role ppargamma placentation specific trophoblast expression
within human placenta, provided evidence activating ppargamma
human cytomegalovirus dramatically impaired early human trophoblast migration and
invasiveness, assessed using well-established vitro models invasive
trophoblast, i.e., primary cultures extravillous cytotrophoblasts (evct)
isolated first-trimester placentas evct-derived cell line hipec. our
data provide new clues explain early infection pregnancy could
impair implantation placentation therefore embryonic development.

doi: 10.1128/jvi.01779-09 
pmcid: pmc2826069
pmid: 20042507  [indexed medline]

